DRAVPa2221 |
Sequence 32 from Patent CN116874560A |
Synthetic peptide |
FAdV-4 |
CN116874560A |
DRAVPa2222 |
Sequence 47 from Patent US20140294942A1 |
Synthetic peptide |
vsv |
US20140294942A1 |
DRAVPa2223 |
Sequence 48 from Patent US20140294942A1 |
Synthetic peptide |
vsv |
US20140294942A1 |
DRAVPa2224 |
Sequence 29 from Patent US20210380642B2 |
Synthetic peptide |
Ebolavirus,Marburg virus |
US20210380642B2 |
DRAVPa2225 |
Sequence 30 from Patent US20210380642B2 |
Synthetic peptide |
Ebolavirus,Marburg virus |
US20210380642B2 |
DRAVPa2226 |
Sequence 31 from Patent US20210380642B2 |
Synthetic peptide |
Ebolavirus,Marburg virus |
US20210380642B2 |
DRAVPa2227 |
Sequence 32 from Patent US20210380642B2 |
Synthetic peptide |
Ebolavirus,Marburg virus |
US20210380642B2 |
DRAVPa2228 |
Sequence 33 from Patent US20210380642B2 |
Synthetic peptide |
Ebolavirus,Marburg virus |
US20210380642B2 |
DRAVPa2229 |
Sequence 34 from Patent US20210380642B2 |
Synthetic peptide |
Ebolavirus,Marburg virus |
US20210380642B2 |
DRAVPa2230 |
Sequence 35 from Patent US20210380642B2 |
Synthetic peptide |
Ebola virus,Marburg virus |
US20210380642B2 |
DRAVPa2231 |
Sequence 36 from Patent US20210380642B2 |
Synthetic peptide |
Ebolavirus,Marburg virus |
US20210380642B2 |
DRAVPa2232 |
Sequence 37 from Patent US20210380642B2 |
Synthetic peptide |
Ebolavirus,Marburg virus |
US20210380642B2 |
DRAVPa2233 |
Sequence 38 from Patent US20210380642B2 |
Synthetic peptide |
Ebolavirus,Marburg virus |
US20210380642B2 |
DRAVPa2234 |
Sequence 43 from Patent US20070073039A1 |
Hepatitis C Virus |
HCV,Dengue viral |
US20070073039A1 |
DRAVPa2235 |
Sequence 92 from Patent US20070073039A1 |
Hepatitis C Virus |
Dengue viral |
US20070073039A1 |
DRAVPa2236 |
Sequence 107 from Patent US20070073039A1 |
Hepatitis C Virus |
Dengue viral |
US20070073039A1 |
DRAVPa2237 |
Sequence 6 from Patent US20070073039A1 |
Hepatitis C Virus |
HCV |
US20070073039A1 |
DRAVPa2238 |
Sequence 8 from Patent US20070073039A1 |
Hepatitis C Virus |
HCV |
US20070073039A1 |
DRAVPa2239 |
Sequence 12 from Patent US20070073039A1 |
Hepatitis C Virus |
HCV |
US20070073039A1 |
DRAVPa2240 |
Sequence 13 from Patent US20070073039A1 |
Hepatitis C Virus |
HCV |
US20070073039A1 |